“Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.”, Biol Blood Marrow Transplant, vol. 18, no. 9, pp. 1368-77, 2012.
, “Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality.”, Transfusion, vol. 54, no. 2, pp. 340-52, 2014.
,